Haladhar Dev Sarma Selected Research

Haladhar Dev Sarma Research Topics

Disease

34	Neoplasms (Cancer) 02/2024 - 04/2007
6	Pain (Aches) 10/2022 - 12/2004
6	Melanoma (Melanoma, Malignant) 12/2020 - 06/2014
5	Fibrosarcoma 06/2023 - 01/2016
5	Neoplasm Metastasis (Metastasis) 10/2022 - 09/2008
4	Infections 11/2023 - 01/2017
4	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 04/2014
3	Breast Neoplasms (Breast Cancer) 09/2022 - 11/2010
2	Hyperthermia 01/2017 - 04/2007
2	Arthritis (Polyarthritis) 06/2009 - 05/2006
1	Bacterial Infections (Bacterial Infection) 11/2023
1	Hypoxia (Hypoxemia) 05/2021
1	Glioblastoma (Glioblastoma Multiforme) 12/2020
1	Liver Neoplasms (Liver Cancer) 07/2020
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2017
1	Hepatocellular Carcinoma (Hepatoma) 10/2010
1	Inflammation (Inflammations) 06/2009

Drug/Important Bio-Agent (IBA)

7	AcidsIBA 11/2023 - 12/2004
6	Peptides (Polypeptides)IBA 03/2023 - 03/2017
5	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 11/2023 - 01/2017
4	Radioisotopes (Radionuclides)IBA 10/2022 - 12/2004
3	Pentetic Acid (DTPA)FDA LinkGeneric 02/2024 - 11/2014
3	Chelating AgentsIBA 11/2023 - 07/2018
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2023 - 11/2013
3	RadiopharmaceuticalsIBA 12/2020 - 12/2004
3	N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA 12/2019 - 03/2017
3	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 10/2019 - 07/2018
3	NGR peptideIBA 07/2019 - 01/2018
3	Bevacizumab (Avastin)FDA Link 05/2017 - 11/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2017 - 11/2014
2	human ERBB2 proteinIBA 02/2024 - 02/2023
2	Trastuzumab (Herceptin)FDA Link 02/2024 - 02/2023
2	ubiquicidin 31-38IBA 11/2023 - 07/2018
2	Cetuximab (Erbitux)FDA Link 06/2023 - 01/2016
2	Monoclonal AntibodiesIBA 06/2023 - 01/2016
2	LigandsIBA 12/2019 - 01/2018
2	IntegrinsIBA 10/2019 - 03/2017
2	ribosomal protein S30IBA 07/2018 - 01/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2017 - 10/2016
2	PorphyrinsIBA 11/2013 - 07/2010
1	pertuzumabIBA 02/2024
1	Antimicrobial PeptidesIBA 11/2023
1	Immunoglobulin Fc FragmentsIBA 06/2023
1	Immunoglobulin Fab FragmentsIBA 06/2023
1	Bombesin Receptors (Bombesin Receptor)IBA 03/2023
1	Therapeutic UsesIBA 02/2023
1	Calcium-45IBA 10/2022
1	SolventsIBA 10/2022
1	azomycinIBA 05/2021
1	NitroimidazolesIBA 05/2021
1	cupric chloride (copper(II) chloride)FDA Link 12/2020
1	gallium 68 PSMA-11IBA 12/2019
1	arginyl-glycyl-aspartic acidIBA 10/2019
1	Rituximab (Mabthera)FDA Link 10/2019
1	cyclic arginine-glycine-aspartic acid peptideIBA 05/2019
1	Arginine (L-Arginine)FDA Link 05/2019
1	Aspartic Acid (Aspartate)FDA Link 05/2019
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2019
1	1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid) (DOTMP)IBA 01/2019
1	Gallium-68IBA 07/2018
1	glycyl-glycyl-glycine (triglycine)IBA 04/2018
1	CarbonIBA 04/2018
1	AmidesIBA 04/2018
1	cyclo(aspargyl-glycyl-arginyl)IBA 01/2018
1	SamariumIBA 01/2018
1	samarium Sm-153 lexidronam (Quadramet)FDA Link 01/2018
1	CD13 Antigens (Alanine Aminopeptidase)IBA 01/2018
1	asparagine-glycine-arginineIBA 01/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2017
1	Tyrosine Kinase InhibitorsIBA 10/2017
1	1,3,4,6-tetrachloro-3 alpha,6 alpha-diphenylglycolurilIBA 05/2017
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 03/2017
1	ferric oxide (iron oxide)IBA 01/2017
1	Dextrans (Dextran)FDA Link 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	SuspensionsIBA 01/2017
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Octreotide (Sandostatin)FDA LinkGeneric 04/2015
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2015
1	perfluorosulfonic acid (Nafion)IBA 06/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2010
1	Progesterone FDA LinkGeneric 11/2010
1	Oxyquinoline (8 Hydroxyquinoline)FDA Link 10/2010
1	Ethiodized Oil (Ethiodol)FDA Link 10/2010
1	Freund's AdjuvantIBA 06/2009
1	177Lu- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid)IBA 09/2008

Therapy/Procedure

6	Therapeutics 06/2019 - 07/2010
3	Precision Medicine 02/2024 - 01/2016
2	Palliative Care (Palliative Therapy) 10/2022 - 02/2016
2	Radiotherapy 07/2020 - 09/2008
2	Intravenous Injections 07/2018 - 04/2007
2	Radioimmunotherapy 05/2017 - 01/2016
2	Brachytherapy 04/2014 - 08/2008
2	Intra-Articular Injections 06/2009 - 05/2006
1	Intravenous Administration 05/2019
1	Nanospheres 04/2018
1	Drug Therapy (Chemotherapy) 01/2017
1	Gamma Cameras (Gamma Camera) 07/2010